Contact
searchSearch
HMP Global

Venous Disease

Features

Chronic Venous Disease
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for...
04/21/2026
Vascular Disease Management
Post-Thrombotic Syndrome
Pivotal Study of Minimally Invasive Stent Therapy Shows Improved Quality of Life for Patients With Blood Clots
04/12/2026
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial...
04/12/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
Alexander Misono, MD, MBA, RPVI
ISET 2026
Lower Extremity Venous Duplex Imaging: Why the Details Matter More Than Ever
02/09/2026
Alexander Misono, MD, MBA, RPVI
Alexander Misono, MD, MBA, RPVI, challenged attendees to rethink how lower extremity venous duplex imaging fits into the modern DVT care pathway.
Alexander Misono, MD, MBA, RPVI, challenged attendees to rethink how lower extremity venous duplex imaging fits into the modern DVT care pathway.
Alexander Misono, MD, MBA, RPVI,...
02/09/2026
Vascular Disease Management
Interview
Evaluating Superficial Venous Disease: When and How to Assess for Deep Venous Obstruction
02/02/2026
Gloria Salazar, MD, FSIR
Dr Salazar emphasizes the importance of maintaining a comprehensive, systems-based approach to venous assessment.
Dr Salazar emphasizes the importance of maintaining a comprehensive, systems-based approach to venous assessment.
Dr Salazar emphasizes the...
02/02/2026
Vascular Disease Management
Cees Wittens, MD
LINC 2026
A New Modular Approach to Venous Stenting With ALTA's Multi-Segmented, Tapered Design
01/26/2026
Cees Wittens, MD
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor...
01/26/2026
Vascular Disease Management
Gerard O'Sullivan, MD
LINC 2026
Tips and Tricks in IVC Reconstruction
01/26/2026
Gerard J. O'Sullivan, MD
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD,...
01/26/2026
Vascular Disease Management
Interview
Are Lytic-Based Thrombectomy Devices Still Relevant?
01/12/2026
Nicolas J. Mouawad, MD, MPH, MBA
Nicolas J. Mouawad, MD, asks if lytic-based thrombectomy is still relevant and discusses how non–lytic-based therapies provide a better safety profile and lower bleeding risk.
Nicolas J. Mouawad, MD, asks if lytic-based thrombectomy is still relevant and discusses how non–lytic-based therapies provide a better safety profile and lower bleeding risk.
Nicolas J. Mouawad, MD, asks if...
01/12/2026
Vascular Disease Management
Deep Venous Disease
Gore Gains FDA Approval for First Deep Venous Stent Indicated for the IVC and Iliofemoral Veins
01/06/2026
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA...
01/06/2026
Vascular Disease Management

Videos & Podcasts

Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Video
Venous Thromboembolism: A Cost Analysis
10/15/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor...
10/15/2025
Vascular Disease Management
Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Xhorlina Marko, MD
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Dr Osman Ahmed
ISET 2024
Management of Acute and Chronic Lower Extremity Venous Obstruction
03/05/2024

Osman Ahmed, MD
UChicago Medicine, Chicago, Illinois

Osman Ahmed, MD UChicago Medicine, Ch...
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed...
03/05/2024
Vascular Disease Management
Dr Daye
ISET 2024
Potential AI Applications for Intervention; AI for Venous Disease
02/09/2024
Dania Daye, MD, PhD
In this video, Dr. Dania Daye discusses her ISET 2024 presentations on the use of artificial intelligence in interventional specialties.
In this video, Dr. Dania Daye discusses her ISET 2024 presentations on the use of artificial intelligence in interventional specialties.
In this video, Dr. Dania Daye...
02/09/2024
Vascular Disease Management
Dr Sista
ISET 2024
Update on the Data: Devices for Treatment of Pulmonary Embolism
02/09/2024
Akhilesh K. Sista, MD
Dr Akhilesh Sista discusses his ISET 2024 presentation on the latest data from current studies on treating pulmonary embolism with catheter-directed therapy.
Dr Akhilesh Sista discusses his ISET 2024 presentation on the latest data from current studies on treating pulmonary embolism with catheter-directed therapy.
Dr Akhilesh Sista discusses his...
02/09/2024
Vascular Disease Management
Dr N'Dandu
AMP 2023
Latest Results of the PROMISE II US Pivotal Trial of the LimFlow System
10/04/2023
In this video recorded at AMP 2023, interventional cardiologist Zola N'Dandu, MD, discusses his presentation on the latest results of the PROMISE II U.S. Pivotal Trial, which investigated the safety and effectiveness of the LimFlow System.
In this video recorded at AMP 2023, interventional cardiologist Zola N'Dandu, MD, discusses his presentation on the latest results of the PROMISE II U.S. Pivotal Trial, which investigated the safety and effectiveness of the LimFlow System.
In this video recorded at AMP...
10/04/2023
Vascular Disease Management
Drs Ahmed, Paul, Secemsky, and Sista
Vascular Voices Podcast
Pulmonary Embolism: Where We Are and Where We’re Going
02/15/2023
Osman Ahmed, MD; Akhilesh K. Sista, MD; Jonathan D. Paul, MD; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
In this episode of Vascular Voices, interventional radiologists Osman Ahmed, MD and Akhi Sista, MD and interventional cardiologists Jonathan Paul, MD and Eric Secemsky, MD discuss the latest advancements in pulmonary embolism treatment.
In this episode of Vascular Voices, interventional radiologists Osman Ahmed, MD and Akhi Sista, MD and interventional cardiologists Jonathan Paul, MD and Eric Secemsky, MD discuss the latest advancements in pulmonary embolism treatment.
In this episode of Vascular...
02/15/2023
Vascular Disease Management
Dr Rundback
ISET 2023
Expected Duplex Findings After DVA and How These Evolve
02/09/2023
John H. Rundback, MD, FAHA, FSIR
Watch as Interventional Radiologist Dr. John Rundback describes his presentation on duplex findings after deep venous arterialization at ISET 2023.
Watch as Interventional Radiologist Dr. John Rundback describes his presentation on duplex findings after deep venous arterialization at ISET 2023.
Watch as Interventional...
02/09/2023
Vascular Disease Management
Venclose Maven
VIdeos
Venclose Maven: The Only 360° RF Solution for the Treatment of Incompetent Perforator Veins
11/10/2022
Learn about the Venclose Maven Perforator Catheter from BD Venous.
Learn about the Venclose Maven Perforator Catheter from BD Venous.
Learn about the Venclose Maven...
11/10/2022
Vascular Disease Management
Michael Pishvaian headshot
Interview
Intra-Arterial Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
06/15/2026
Michael Pishvaian, MD, PhD
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD,...
06/15/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Sanjay Misra speaks at ISET 2026
ISET 2026
Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes
03/25/2026
Sanjay Misra, MD, FSIR, FAHA, FACR
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist...
03/25/2026
Vascular Disease Management
Dr William Gray speaking at ISET
ISET 2026
Three-Year Outcomes from the PERFORMANCE II Trial: A Prospective Multicenter Study of the Neuroguard IEP® 3-in-1 Carotid Stent System
03/24/2026
William A. Gray, MD, FACC, FSCAI
Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into safety, efficacy, and sustained performance.
Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into safety, efficacy, and sustained performance.
Dr. Gray reviews the study’s...
03/24/2026
Vascular Disease Management

Presentations

Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
Alexander Misono, MD, MBA, RPVI
ISET 2026
Lower Extremity Venous Duplex Imaging: Why the Details Matter More Than Ever
02/09/2026
Alexander Misono, MD, MBA, RPVI
Alexander Misono, MD, MBA, RPVI, challenged attendees to rethink how lower extremity venous duplex imaging fits into the modern DVT care pathway.
Alexander Misono, MD, MBA, RPVI, challenged attendees to rethink how lower extremity venous duplex imaging fits into the modern DVT care pathway.
Alexander Misono, MD, MBA, RPVI,...
02/09/2026
Vascular Disease Management
Cees Wittens, MD
LINC 2026
A New Modular Approach to Venous Stenting With ALTA's Multi-Segmented, Tapered Design
01/26/2026
Cees Wittens, MD
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor...
01/26/2026
Vascular Disease Management
Gerard O'Sullivan, MD
LINC 2026
Tips and Tricks in IVC Reconstruction
01/26/2026
Gerard J. O'Sullivan, MD
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD,...
01/26/2026
Vascular Disease Management
Dr Harnain
ISET 2025
Case Studies & Discussion: Venous Compression Syndromes
02/02/2025
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M....
02/02/2025
Vascular Disease Management
Dr Jaffer
LINC 2025
Creating EndoAVF: New Evidence and Upcoming Trials
01/30/2025
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked...
01/30/2025
Vascular Disease Management
Dr Hirsch
LINC 2025
Odds and Limitations of Duplex Sonography in the Diagnosis of PeVD
01/28/2025
Tobias Hirsch, MD
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his...
01/28/2025
Vascular Disease Management
Dr Schlager
LINC 2024
Quality of Life PROMinance Vital in Venous Interventions
05/29/2024

Oliver Schlager, MD
Medical University of Vienna, Austria

Oliver Schlager, MD Medical Universit...
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were...
05/29/2024
Vascular Disease Management
Dr Suai
LINC 2024
AVF Treatment Leaves a Great IMPRESSION
05/28/2024

Tan Chieh Suai
Singapore General Hospital, Singapore

Tan Chieh Suai Singapore General Hosp...
The first data from a randomized controlled trial looking into the treatment of arteriovenous fistula (AVF) stenosis was announced today by Dr Tan Chieh Suai from Singapore General Hospital.
The first data from a randomized controlled trial looking into the treatment of arteriovenous fistula (AVF) stenosis was announced today by Dr Tan Chieh Suai from Singapore General Hospital.
The first data from a randomized...
05/28/2024
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr Elizabeth Genovese
ISET 2026
When Do I Think of a Bypass? Reframing Revascularization Decisions in CLTI
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
John Rundback MD
ISET 2026
Vessel Preparation for Tibial Interventions: Why “Just PTA” Is Rarely Enough
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Sean P. Lyden, MD
ISET 2026
Real-World Acute Limb Ischemia: What the PROWL Registry Is Teaching Us
02/10/2026
Sean P. Lyden, MD
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new...
02/10/2026
Vascular Disease Management
Dr Andrew Holden
ISET 2026
Bioresorbable Scaffolds in BTK Disease: Where We Are and Where We’re Headed
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
Ripal T. Gandhi, MD
ISET 2026
Single-Use Handheld Vascular Robotics: What Is the Future?
02/10/2026
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM,...
02/10/2026
Vascular Disease Management
James F. Meschia, MD
ISET 2026
Redefining Optimal Medical Therapy in Carotid Disease: Key Lessons from CREST-2
02/09/2026
James F. Meschia, MD
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides...
02/09/2026
Vascular Disease Management
Nicos Labropoulos, MD
ISET 2026
Beyond Stenosis: Identifying the Truly High-Risk Carotid Plaque
02/09/2026
Nicos Labropoulos, MD
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented...
02/09/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Chronic Venous Disease
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for...
04/21/2026
Vascular Disease Management
Post-Thrombotic Syndrome
Pivotal Study of Minimally Invasive Stent Therapy Shows Improved Quality of Life for Patients With Blood Clots
04/12/2026
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial finds opportunity to treat often ignored DVT complication. TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome...
NIH-sponsored C-TRACT Trial...
04/12/2026
Vascular Disease Management
Deep Venous Disease
Gore Gains FDA Approval for First Deep Venous Stent Indicated for the IVC and Iliofemoral Veins
01/06/2026
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA...
01/06/2026
Vascular Disease Management
Venous Leg Ulcers
Spectrum Venous Leg Ulcer Study Demonstrates Clinical Support for Use of VenaSeal™ in Advanced Superficial Venous Disease
04/24/2025
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate...
04/24/2025
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
The US FDA has approved its IDE application to initiate the QUADRA-PE study (NCT06672510) evaluating the Katana™ Thrombectomy System in patients with acute PE.
The US FDA has approved its IDE application to initiate the QUADRA-PE study (NCT06672510) evaluating the Katana™ Thrombectomy System in patients with acute PE.
The US FDA has approved its IDE...
11/04/2024
Vascular Disease Management
Zilver Vena Stent
Zilver Vena Stent Shows High Patency Across All Patient Groups in Three-Year Clinical Study
10/29/2024
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook...
10/29/2024
Vascular Disease Management
Venous Disease
New Randomized Controlled Data From Venaseal Spectrum Program Reinforces Evidence That Venaseal™ Closure System Is Safe and Effective
04/24/2024

Medtronic News Alert

Medtronic News Alert
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in...
04/24/2024
Vascular Disease Management
News
Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs
04/05/2024

Clarius Mobile Health News

Clarius Mobile Health News
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for...
04/05/2024
Vascular Disease Management
Abdominal Aortic Aneurysm
Data Presented on Two-Year Proximal Neck Dynamics From First-in-Human Study of Abdominal Aortic Aneurysm Treatment
06/26/2026
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 –...
06/26/2026
Vascular Disease Management
New Guiding Sheath
Volante™ Steerable Guiding Sheath Now Available in US
06/23/2026
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The...
06/23/2026
Vascular Disease Management
Clinical Trials
SYMPHONY-PE Trial Post-Hoc Analysis Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism
06/18/2026
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12...
06/18/2026
Cath Lab Digest
Team Communication
IB Nimble 2 Adds In-App DICOM Viewing for Real-Time Multidisciplinary Collaboration
06/17/2026
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is...
06/17/2026
Cath Lab Digest
CE Mark
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
06/16/2026
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer...
06/16/2026
Cath Lab Digest
FDA Clearance
Penumbra’s THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
06/15/2026
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™,...
06/15/2026
Cath Lab Digest
Veterans With PAD
Department of Veteran Affairs Referrals for Peripheral Artery Disease Nearly Triples Over the Past Five Years
06/15/2026
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans...
06/15/2026
Cath Lab Digest
Thrombolex, Inc.
Thrombolex, Inc. Names Michael Tutera Chief Executive Officer
06/12/2026
New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, June 15, 2026 –...
06/12/2026
Vascular Disease Management
PAD Guidelines
VAM26: Complete Adherence to Guideline-Directed Care Associated with Decreased Serious Limb Complications at Two Years
06/10/2026
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
“Our study was designed to...
06/10/2026
Cath Lab Digest
Thrombectomy
First-in-Human Clinical Success with Novel Mechanical Thrombectomy System
06/09/2026
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
"The V-PULSE system removed...
06/09/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use